NM_000429.3:c.98T>A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_000429.3(MAT1A):c.98T>A(p.Ile33Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000429.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
MAT1A-related disorder Uncertain:1
The MAT1A c.98T>A variant is predicted to result in the amino acid substitution p.Ile33Asn. This variant was reported in a study investigating the performance of whole exome sequencing as the primary newborn screen in California. The variant was detected, heterozygous, in one individual who had a positive newborn screen by MS/MS for Hypermethioninemia (Table S5, Adhikari et al. 2020. PubMed ID: 32778825). Although the authors noted that two variants were detected, the identity of the second variant remains unclear. It is also unclear if the individual carrying p.Ile33Asn variant was clinically affected. This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Hepatic methionine adenosyltransferase deficiency Uncertain:1
This sequence change replaces isoleucine with asparagine at codon 33 of the MAT1A protein (p.Ile33Asn). The isoleucine residue is highly conserved and there is a large physicochemical difference between isoleucine and asparagine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with MAT1A-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at